(Q22252532)

7 February 2023

Martha Radford

3

Martha

Radford

1 reference

24927909

7 February 2023

Philip James Devereaux

P.J. Devereaux

8

P J

Devereaux

1 reference

7 February 2023

Sripal Bangalore

1

Sripal

Bangalore

1 reference

7 February 2023

Kamia Thakur

4

Kamia

Thakur

1 reference

24927909

7 February 2023

James J. DiNicolantonio

series ordinal

7

object named as

James J. DiNicolantonio

author given names

James J

author last names

DiNicolantonio

1 reference

7 February 2023

11

Franz H. Messerli

Franz H

Messerli

1 reference

ORCID Public Data File 2021

7 February 2023

1 reference

2

Harikrishna Makani

Harikrishna

Makani

1 reference

7 February 2023

5

Bora Toklu

Bora

Toklu

1 reference

7 February 2023

Karen P. Alexander

9

Karen P

Alexander

1 reference

24927909

American Journal of Medicine

7 February 2023

Jorn Wetterslev

series ordinal

10

0 references

language of work or name

English

0 references

publication date

October 2014

0 references

published in

0 references

volume

127

0 references

issue

10

0 references

page(s)

939-953

0 references

cites work

Does aspirin consumption affect the presentation or severity of acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Thromboatherosclerotic complications in hypertensives: results of the Stockholm Metoprolol (secondary prevention) Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Treatment of acute myocardial infarction with propranolol

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Comparison of the effects of beta blockers and calcium antagonists on cardiovascular events after acute myocardial infarction in Japanese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Effect of intravenous metoprolol before hospital admission on chest pain in suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Reduction of infarct size by the early use of intravenous timolol in acute myocardial infarction. International Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction. The APSI Investigators. Acebutolol et Prévention Secondaire de l'Infarctus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Potassium, glucose, and insulin in treatment of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Absence of prophylactic effect of propranolol in myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Letter: Reduction of sudden Deaths after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Controlled trial of sotalol for one year after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Coronary artery disease. Are β-blockers truly helpful in patients with CAD?

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

A comparison of metoprolol and morphine in the treatment of chest pain in patients with suspected acute myocardial infarction--the MEMO study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

A long-term prevention study with oxprenolol in coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Esmolol in acute ischemic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

1 reference

7 January 2021

An early intervention secondary prevention study with oxprenolol following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Very early intervention with metoprolol in suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Effect of labetalol on indices of myocardial necrosis in patients with suspected acute infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Effects on mortality during five years after early intervention with metoprolol in suspected acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Trial of propranolol in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Interaction revisited: the difference between two estimates

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Effects of early use of atenolol or captopril on infarct size and ventricular volume: A double-blind comparison in patients with anterior acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Beneficial effects of timolol on infarct size and late ventricular tachycardia in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNI

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Estimating required information size by quantifying diversity in random-effects model meta-analyses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021

Secondary preventive effects of a calcium antagonist for ischemic heart attack: randomized parallel comparison with β-blockers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJMED.2014.05.032

7 January 2021